The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5

被引:29
作者
Ahmad, Iqbal [1 ]
Li, Sunan [1 ]
Li, Rongrong [1 ]
Chai, Qingqing [2 ]
Zhang, Lixin [1 ]
Wang, Bin [1 ]
Yu, Chongqing [1 ]
Zheng, Yong-Hui [1 ,2 ]
机构
[1] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, CAAS Michigan State Univ Joint Lab Innate Immun, Harbin Vet Res Inst, Harbin 150069, Heilongjiang, Peoples R China
[2] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA
基金
中国博士后科学基金; 美国国家卫生研究院; 中国国家自然科学基金;
关键词
virus; virus entry; host-pathogen interaction; innate immunity; viral protein; EIAV S2; HIV Nef; MLV glycoGag; restriction factor; SERINC5; EQUINE INFECTIOUS-ANEMIA; HIV-1; NEF; DOWN-REGULATION; FEBRILE EPISODES; VIRUS; GENE; FAMILY;
D O I
10.1074/jbc.RA119.007662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine incorporator 5 (SERINC5) is a recently identified restriction factor that blocks virus entry but is antagonized by three unrelated retroviral accessory proteins. The S2 protein from equine infectious anemia virus (EIAV) has been reported to reduce SERINC5 expression at steady-state levels likely via the endocytic pathway; however, the precise mechanism is still unclear. Here, we investigated how EIAV S2 protein down-regulates SERINC5 compared with down-regulation induced by Nef from HIV-1 and glycoMA proteins from murine leukemia virus (MLV). Using bimolecular fluorescence complementation (BiFC) assay and immunoprecipitation (IP), we detected an interaction between S2 and SERINC5. We found that this interaction relies on the S2 myristoylation site, indicating that it may occur on the plasma membrane. S2 internalized SERINC5 via receptor-mediated endocytosis and targeted it to endosomes and lysosomes, resulting in a ubiquitination-dependent decrease in SERINC5 expression at steady-state levels. Both BiFC and IP detected a glycoMA-SERINC5 interaction, but a Nef-SERINC5 interaction was detected only by BiFC. Moreover, S2 and glycoMA down-regulated SERINC5 more effectively than did Nef. We further show that unlike Nef, both S2 and glycoMA effectively down-regulate SERINC2 and also SERINC5 from Xenopus tropicalis (xSERINC5). Moreover, we detected expression of the equine SERINC5 (eSERINC5) protein and observed that its expression is much weaker than expression levels of SERINC5 from other species. Nonetheless, eSERINC5 had a strong antiviral activity that was effectively counteracted by S2. We conclude that HIV-1, EIAV, and MLV share a similar mechanism to antagonize viral restriction by host SERINC5.
引用
收藏
页码:7013 / 7024
页数:12
相关论文
共 29 条
[1]   Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins [J].
Ahi, Yadvinder S. ;
Zhang, Shu ;
Thappeta, Yashna ;
Denman, Audrey ;
Feizpour, Amin ;
Gummuluru, Suryaram ;
Reinhard, Bjoern ;
Muriaux, Delphine ;
Fivash, Matthew J. ;
Rein, Alan .
MBIO, 2016, 7 (06)
[2]   Interaction with the Src Homology (SH3-SH2) Region of the Src-family Kinase Hck Structures the HIV-1 Nef Dimer for Kinase Activation and Effector Recruitment [J].
Alvarado, John Jeff ;
Tarafdar, Sreya ;
Yeh, Joanne I. ;
Smithgall, Thomas E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (41) :28539-28553
[3]   Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein [J].
Bentham, M ;
Mazaleyrat, S ;
Harris, M .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :563-571
[4]   S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 [J].
Chande, Ajit ;
Cuccurullo, Emilia Cristiana ;
Rosa, Annachiara ;
Ziglio, Serena ;
Carpenter, Susan ;
Pizzato, Massimo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (46) :13197-13202
[5]   Equine infectious anemia and equine infectious anemia virus in 2013: A review [J].
Cook, R. F. ;
Leroux, C. ;
Issel, C. J. .
VETERINARY MICROBIOLOGY, 2013, 167 (1-2) :181-204
[6]   Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity [J].
Craig, HM ;
Pandori, MW ;
Guatelli, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11229-11234
[7]   A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef [J].
Dai, Weiwei ;
Usami, Yoshiko ;
Wu, Yuanfei ;
Gottlinger, Heinrich .
CELL REPORTS, 2018, 22 (04) :869-875
[8]   The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists [J].
de Sousa-Pereira, Patricia ;
Abrantes, Joana ;
Bauernfried, Stefan ;
Pierini, Virginia ;
Esteves, Pedro Jose ;
Keppler, Oliver T. ;
Pizzato, Massimo ;
Hornung, Veit ;
Fackler, Oliver T. ;
Baldauf, Hanna-Mari .
JOURNAL OF GENERAL VIROLOGY, 2019, 100 (02) :278-288
[9]   GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS [J].
DEACON, NJ ;
TSYKIN, A ;
SOLOMON, A ;
SMITH, K ;
LUDFORDMENTING, M ;
HOOKER, DJ ;
MCPHEE, DA ;
GREENWAY, AL ;
ELLETT, A ;
CHATFIELD, C ;
LAWSON, VA ;
CROWE, S ;
MAERZ, A ;
SONZA, S ;
LEARMONT, J ;
SULLIVAN, JS ;
CUNNINGHAM, A ;
DWYER, D ;
DOWTON, D ;
MILLS, J .
SCIENCE, 1995, 270 (5238) :988-991
[10]   The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies [J].
Fagerness, Angela J. ;
Flaherty, Maureen T. ;
Perry, Stephanie T. ;
Jia, Bin ;
Payne, Susan L. ;
Fuller, Frederick J. .
VIROLOGY, 2006, 349 (01) :22-30